Come up with a name for your new list and we'll add to it:
GeneCentric Diagnostics raised a round of funding on July 11, 2013. Investors include
Hatteras Venture Partners.
GeneCentric Diagnostics focuses on the development and commercialization of molecular diagnostic assays that enable oncologists and patients to make more informed, individualized treatment decisions.…